RaQualia Pharma Inc. (TYO:4579)

RaQualia Pharma Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,533	3,340	3,714	3,675	2,345	1,394
Short-Term Investments	89	1	49	250	313	719
Cash & Short-Term Investments	3,622	3,341	3,763	3,925	2,658	2,113
Cash Growth	12.73%	-11.21%	-4.13%	47.67%	25.79%	-3.96%
Receivables	714	689	603	602	1,205	530
Inventory	171	167	147	8	10	6
Prepaid Expenses	309	193	188	108	90	50
Other Current Assets	92	148	255	179	40	135
Total Current Assets	4,908	4,538	4,956	4,822	4,003	2,834
Property, Plant & Equipment	526	529	573	391	299	332
Long-Term Investments	624	607	1,306	1,020	897	1,049
Goodwill	3,766	3,865	-	-	-	-
Other Intangible Assets	34	37	30	24	33	33
Long-Term Deferred Tax Assets	75	78	5	-	-	2
Other Long-Term Assets	3	1	1	-	2	1
Total Assets	9,936	9,655	6,871	6,257	5,234	4,251
Accounts Payable	54	59	54	128	45	42
Accrued Expenses	69	69	54	60	63	49
Current Portion of Long-Term Debt	512	512	12	2	-	-
Current Portion of Leases	76	69	64	42	21	18
Current Income Taxes Payable	193	221	178	237	230	73
Other Current Liabilities	119	257	27	24	41	4
Total Current Liabilities	1,023	1,187	389	493	400	186
Long-Term Debt	2,395	2,651	39	9	-	-
Long-Term Leases	212	218	251	167	17	27
Long-Term Deferred Tax Liabilities	-	-	-	2	16	14
Other Long-Term Liabilities	20	28	73	89	15	15
Total Liabilities	3,650	4,084	752	760	448	242
Common Stock	3,240	2,720	2,667	2,265	2,256	2,255
Additional Paid-In Capital	3,430	2,910	2,857	2,455	2,446	2,445
Retained Earnings	-400	-45	449	773	49	-706
Comprehensive Income & Other	16	-14	146	4	35	15
Shareholders' Equity	6,286	5,571	6,119	5,497	4,786	4,009
Total Liabilities & Equity	9,936	9,655	6,871	6,257	5,234	4,251
Total Debt	3,195	3,450	366	220	38	45
Net Cash (Debt)	427	-109	3,397	3,705	2,620	2,068
Net Cash Growth	-	-	-8.31%	41.41%	26.69%	-5.96%
Net Cash Per Share	19.16	-5.04	157.22	176.57	124.93	98.71
Filing Date Shares Outstanding	24.46	21.84	21.62	21.6	20.96	20.95
Total Common Shares Outstanding	24.46	21.84	21.62	20.98	20.95	20.95
Working Capital	3,885	3,351	4,567	4,329	3,603	2,648
Book Value Per Share	257.02	255.10	282.98	262.05	228.43	191.35
Tangible Book Value	2,486	1,669	6,089	5,473	4,753	3,976
Tangible Book Value Per Share	101.65	76.43	281.60	260.90	226.86	189.77

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.